Trinity Biotech PLC (TRIB)
1.83
+0.02
(+1.10%)
USD |
NASDAQ |
Apr 23, 16:00
Trinity Biotech Shareholders Equity (Quarterly): -17.49M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -17.49M |
June 30, 2023 | -11.38M |
March 31, 2023 | -6.618M |
December 31, 2022 | -2.176M |
September 30, 2022 | 6.633M |
June 30, 2022 | 15.82M |
March 31, 2022 | -6.285M |
December 31, 2021 | -0.319M |
September 30, 2021 | 0.81M |
June 30, 2021 | -0.496M |
March 31, 2021 | -0.127M |
December 31, 2020 | -2.219M |
September 30, 2020 | 7.071M |
June 30, 2020 | -0.712M |
March 31, 2020 | 0.768M |
December 31, 2019 | 4.713M |
September 30, 2019 | 38.93M |
June 30, 2019 | 39.07M |
March 31, 2019 | 44.17M |
December 31, 2018 | 44.05M |
September 30, 2018 | 68.08M |
June 30, 2018 | 66.69M |
March 31, 2018 | 65.78M |
December 31, 2017 | 65.20M |
September 30, 2017 | 106.39M |
Date | Value |
---|---|
June 30, 2017 | 106.87M |
March 31, 2017 | 109.28M |
December 31, 2016 | 108.73M |
September 30, 2016 | 210.40M |
June 30, 2016 | 210.66M |
March 31, 2016 | 212.47M |
December 31, 2015 | 213.89M |
September 30, 2015 | 211.00M |
June 30, 2015 | 205.06M |
March 31, 2015 | 201.24M |
December 31, 2014 | 196.97M |
September 30, 2014 | 194.78M |
June 30, 2014 | 196.11M |
March 31, 2014 | 189.01M |
December 31, 2013 | 183.01M |
September 30, 2013 | 175.13M |
June 30, 2013 | 174.82M |
March 31, 2013 | 174.61M |
December 31, 2012 | 169.38M |
September 30, 2012 | 165.06M |
June 30, 2012 | 159.68M |
March 31, 2012 | 159.30M |
December 31, 2011 | 151.33M |
September 30, 2011 | 148.97M |
June 30, 2011 | 147.09M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-17.49M
Minimum
Sep 2023
39.07M
Maximum
Jun 2019
3.667M
Average
-0.223M
Median
Shareholders Equity (Quarterly) Benchmarks
Amarin Corp PLC | 552.10M |
Avadel Pharmaceuticals PLC | 87.74M |
DBV Technologies SA | 140.19M |
Adaptimmune Therapeutics PLC | 39.51M |
Akari Therapeutics PLC | -0.229M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 63.60M |
Total Liabilities (Quarterly) | 81.08M |
Debt to Equity Ratio | -3.116 |
Current Ratio | 3.441 |
Net Debt Paydown Yield | 0.44% |